EXOLIFE Trademark

Trademark Overview


On Monday, October 13, 2025, a trademark application was filed for EXOLIFE with the United States Patent and Trademark Office. The USPTO has given the EXOLIFE trademark a serial number of 99440442. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Tuesday, March 3, 2026. This trademark is owned by PRANAX CORPORATION. The EXOLIFE trademark is filed in the Medical & Beauty Services & Agricultural Services category with the following description:

Collection of exosomes, being vesicles produced by human cells.
exolife

General Information


Serial Number99440442
Word MarkEXOLIFE
Filing DateMonday, October 13, 2025
Status641 - NON-FINAL ACTION - MAILED
Status DateTuesday, March 3, 2026
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Pseudo MarkEXOSOME LIFE
Pseudo MarkEXO LIFE
Goods and ServicesCollection of exosomes, being vesicles produced by human cells.

Classification Information


International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, October 13, 2025
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NamePRANAX CORPORATION
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressPINEHURST, TX 77362
US

Trademark Events


Event DateEvent Description
Monday, October 13, 2025NEW APPLICATION ENTERED
Monday, October 13, 2025APPLICATION FILING RECEIPT MAILED
Wednesday, February 11, 2026NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, March 2, 2026ASSIGNED TO EXAMINER
Tuesday, March 3, 2026NON-FINAL ACTION WRITTEN
Tuesday, March 3, 2026NON-FINAL ACTION E-MAILED
Tuesday, March 3, 2026NOTIFICATION OF NON-FINAL ACTION E-MAILED